SHR0534
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SHR0534, covering 2016-04-22 to 2016-12-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients [Phase 1]